glp 1 and visceral fat loss Myths & Facts: GLP-1 Drugs for Weight GLP-1 Therapy Part 1: Setting

In 2014, Nova Nordisks GLP-1 drug Saxenda was approved by the FDA as a treatment for obesity, and since then, others have followed

Will I feel different right away

This may lead to closer follow-up by medical teams, which may explain these results

Summary: GLP-1 medications slow gut motility and gastric emptying, leading to harder stools and constipation, which can be managed through increased dietary fibre, adequate hydration, regular physical activity, and appropriate laxative use when necessary

Age, certain medications, stomach conditions, and plant-based diets can all interfere with absorption

Madewell ZJ, Keita AM, Das PM, Mehta A, Akelo V, Oluoch OB, Omore R, Onyango D, Sagam CK, Cain CJ, Chukwuegbo C, Kaluma E, Luke R, Ogbuanu IU, Bassat Q, Kincardett M, Mandomando I, Rakislova N, Varo R, Xerinda EG, Dangor Z, du Toit J, Lala SG, Madhi SA, Mahtab S, Breines MR, Degefa K, Heluf H, Madrid L, Scott JAG, Sow SO, Tapia MD, El Arifeen S, Gurley ES, Hossain MZ, Islam KM, Rahman A, Mutevedzi PC, Whitney CG, Blau DM, Suchdev PS, Kotloff KL